Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells

Dingqi Zhanga Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, ChinaView further author information

Lijun Zhanga Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, ChinaView further author information

Gaofeng Chena Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, ChinaView further author information

Ying Xua Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, ChinaView further author information

Hailin Yanga Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, ChinaView further author information

Zhun Xiaob Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, China;c Institute of Interdisciplinary Complex Research, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaView further author information

Jiamei Chena Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, ChinaView further author information

Yongping Mua Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, ChinaView further author information

Hua Zhanga Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, ChinaView further author information

Wei Liua Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, ChinaCorrespondence[email protected]
View further author information

Ping Liua Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China;b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, China;c Institute of Interdisciplinary Complex Research, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaCorrespondence[email protected]
View further author information

show all

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Feipeng Xu, Hua Zhang, Jiamei Chen, Junyi Zhan, Ping Liu, Wei Liu, Shenglan Qi & Yongping Mu. (2024) Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease. Journal of Ethnopharmacology 321, pages 117514.
Crossref

Min Zhang, Xu-Dong Hou, Wei Liu, Lu Wang, Mei-Fang Jiang, Jie Hou, Hui Tang & Guang-Bo Ge. (2023) Uncovering the anti-obesity constituents in Ginkgo biloba extract and deciphering their synergistic effects. Fitoterapia 171, pages 105669.
Crossref

Zhun Xiao, Qiang Ji, Ya-dong Fu, Si-qi Gao, Yong-hong Hu, Wei Liu, Gao-feng Chen, Yong-ping Mu, Jia-mei Chen & Ping Liu. (2021) Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling. Chinese Journal of Integrative Medicine 29:4, pages 316-324.
Crossref

Dengcheng Hui, Lu Liu, Yanqin Bian, Nisma L. B. Azami, Jingru Song, Yanping Huang & Mingyu Sun. (2023) Traditional Chinese medicine targets on hepatic stellate cells for the treatment of hepatic fibrosis: A mechanistic review. Portal Hypertension & Cirrhosis 2:1, pages 16-31.
Crossref

Jianjun Wu, Dingqi Zhang, Bo Zhu, Siqi Wang, Yongbin Xu, Congcong Zhang, Hailing Yang, Shunchun Wang, Ping Liu, Luping Qin & Wei Liu. (2022) Rubus chingii Hu. unripe fruits extract ameliorates carbon tetrachloride-induced liver fibrosis and improves the associated gut microbiota imbalance. Chinese Medicine 17:1.
Crossref

Congcong Zhang, Dingqi Zhang, Yongli Wang, Linzhang Zhang, Shenglan Qi, Qinqin Fang, Ying Xu, Jiamei Chen, Xuemei Cheng, Ping Liu, Changhong Wang & Wei Liu. (2022) Pharmacokinetics and anti-liver fibrosis characteristics of amygdalin: Key role of the deglycosylated metabolite prunasin. Phytomedicine 99, pages 154018.
Crossref

Jie Liang, Hongwei Yuan, Liping Xu, Feng Wang, Xiaomei Bao, Yuxin Yan, Haisheng Wang, Chunyan Zhang, Rong Jin, Lijie Ma, Jianyu Zhang, Lebagen Huri, Xiaoli Su, Rui Xiao & Yuehong Ma. (2021) Study on the effect of Mongolian medicine Qiwei Qinggan Powder on hepatic fibrosis through JAK2/STAT3 pathway. Bioscience, Biotechnology, and Biochemistry 85:4, pages 775-785.
Crossref

Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date